We are live on ! Find out more
Bessemer Group

Bessemer Group Portfolio holdings

AUM $63.6B
1-Year Est. Return 28.76%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$14B
AUM Growth
+$1.63B
Cap. Flow
+$225M
Cap. Flow %
1.61%
Top 10 Hldgs %
16.45%
Holding
1,448
New
199
Increased
366
Reduced
275
Closed
98

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$98.9M
2
GE icon
GE Aerospace
GE
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$92.5M
4
WBA
Walgreens Boots Alliance
WBA
+$67.4M
5
TPR icon
Tapestry
TPR
+$60.5M

Sector Composition

Rank Sector Weight
1 Healthcare 15.01%
2 Technology 14.16%
3 Financials 12.66%
4 Industrials 9.8%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWG icon
151
iShares MSCI Germany ETF
EWG
$1.5B
$9.4M 0.07%
296,000
-37,800
-11% -$1.12M
IWF icon
152
iShares Russell 1000 Growth ETF
IWF
$122B
$9.35M 0.07%
434,864
+1,748
+0.4% +$35.9K
GOOG icon
153
Alphabet (Google) Class C
GOOG
$3.9T
$9.27M 0.07%
332,321
+1,164
+0.4% +$29.4K
FDO
154
DELISTED
FAMILY DOLLAR STORES
FDO
$8.98M 0.06%
138,300
-125,000
-47% -$8.55M
XRAY icon
155
Dentsply Sirona
XRAY
$2.59B
$8.79M 0.06%
181,289
-1,862
-1% -$87.1K
ACWI icon
156
iShares MSCI ACWI ETF
ACWI
$32.6B
$8.74M 0.06%
151,788
+50,847
+50% +$2.85M
DFJ icon
157
WisdomTree Japan SmallCap Dividend Fund
DFJ
$385M
$8.16M 0.06%
160,000
BAX icon
158
Baxter International
BAX
$11.6B
$8.16M 0.06%
215,927
+21,751
+11% +$789K
TEVA icon
159
Teva Pharmaceuticals
TEVA
$35.9B
$8.08M 0.06%
201,704
-2,512,446
-93% -$98.9M
NM
160
DELISTED
Navios Maritime Holdings Inc.
NM
$8.06M 0.06%
72,218
+50,428
+231% +$4.07M
BAC icon
161
Bank of America
BAC
$435B
$8M 0.06%
514,019
-678,428
-57% -$10.1M
DINO icon
162
HF Sinclair
DINO
$15.9B
$7.66M 0.05%
154,200
+2,500
+2% +$114K
DHR icon
163
Danaher
DHR
$135B
$7.64M 0.05%
147,254
+63
+0% +$3.1K
RNR icon
164
RenaissanceRe
RNR
$13.7B
$7.6M 0.05%
78,038
ADP icon
165
Automatic Data Processing
ADP
$100B
$7.38M 0.05%
104,067
+506
+0.5% +$34K
KBR icon
166
KBR
KBR
$4.68B
$7.17M 0.05%
225,000
-150,000
-40% -$4.98M
CPB icon
167
Campbell Soup
CPB
$6.51B
$7.17M 0.05%
165,567
+153,752
+1,301% +$6.37M
CNVR
168
DELISTED
CONVERSANT INC COM STK (DE)
CNVR
$7.01M 0.05%
300,000
DLTR icon
169
Dollar Tree
DLTR
$23.1B
$7M 0.05%
124,120
-1,000
-0.8% -$57.6K
MKC icon
170
McCormick & Company Non-Voting
MKC
$13.4B
$6.79M 0.05%
197,208
+36,034
+22% +$1.23M
ECL icon
171
Ecolab
ECL
$75.6B
$6.5M 0.05%
62,288
-2,798
-4% -$291K
FRAN
172
DELISTED
Francesca's Holdings Corporation
FRAN
$6.44M 0.05%
+29,167
New +$6.36M
BMY icon
173
Bristol-Myers Squibb
BMY
$127B
$6.37M 0.05%
119,851
+22,249
+23% +$1.13M
MYGN icon
174
Myriad Genetics
MYGN
$530M
$6.29M 0.05%
+300,000
New +$7.59M
ALSN icon
175
Allison Transmission
ALSN
$10.1B
$6.29M 0.05%
227,838

Similar funds

Bessemer Group's Q4 2013 Portfolio in Review

As of Q4 2013, Bessemer Group held 1,448 positions worth $14B, up 13% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Bessemer Group's Q4 2013 filing shows 199 new, 366 increased, 275 reduced and 98 closed positions. Its largest new stake was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M. The largest sale was Teva Pharmaceuticals, an estimated $98.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Bessemer Group's largest Q4 2013 buy was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M.
  • Bessemer Group added most to Viatris in Q4 2013, an estimated $154M increase.
  • Bessemer Group's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $98.9M.
  • Bessemer Group fully exited Rayonier in Q4 2013, selling an estimated $33.4M.
  • Bessemer Group's ten largest holdings make up 16% of its $14B portfolio in Q4 2013.
  • Bessemer Group opened 199 new positions and closed 98 in Q4 2013.
  • Bessemer Group's portfolio value rose 13% quarter-over-quarter to $14B.

Based on Bessemer Group's 13F filing for Q4 2013, filed 18 Feb 2014.